ClinicalTrials.gg
RecruitingNCT07608094Updated Nov 12, 2026

The Treatment Outcomes of Cesarean Scar Pregnancy

An observational study in Cesarean Scar Pregnancy, sponsored by Women's Hospital School Of Medicine Zhejiang University. Recruiting at 1 site in China. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Women's Hospital School Of Medicine Zhejiang University · Observational

How we know

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
82
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 42 studies in Cicatrix with a site in China — 8 open to participants now, 8 under way, none of them phase 3. Cicatrix · China.

Started
2025
with 5 others
Observational
8 of 42
1 open now
Registered
30th of 42
by date
Lead sponsor
2 of 42
Women's Hospital School Of Medicine Zhejiang University

Among the 42 studies in Cicatrix with a site in China, this one is one of 6 that started in 2025, is one of 8 observational ones, and was the 30th registered.

Cicatrix

616 studies on the registry are indexed under Cicatrix; 117 are open to participants now.

Browse Cicatrix studies →

Open to participants now

8 of the 42 studies in Cicatrix with a site in China are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 69 Cicatrix studies recruiting now, 34 (49%) set no upper age limit and 31 (45%) stop at 75 or younger; 11 take children under 18; 16 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 42 studies in Cicatrix with a site in China, or all of them as a file.
02

Study summary

A prospective randomized controlled study evaluating the impact of various treatment modalities for cesarean scar pregnancy on treatment outcomes and pregnancy outcomes

Read the detailed description

The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach.

Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.

03

Conditions studied

  • Cesarean Scar Pregnancy

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

A prospective randomized controlled study evaluating the impact of various treatment modalities for cesarean scar pregnancy on treatment outcomes and pregnancy outcomes. The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach.

Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Women over 18 years old with a history of cesarean section
  2. Ultrasound diagnosis of cesarean scar pregnancy
  3. No severe internal or external diseases, such as liver disease, kidney disease, cardiovascular disease, cerebrovascular disease, etc., and able to tolerate surgery

Exclusion criteria

Exclusion Criteria:

  1. Women under the age of 18
  2. CSP patients who have received treatment in other hospitals
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
82 participants (estimated)
Patient registry
No

Groups and cohorts

  • excisional surgery group

    The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach.

    Other: different surgical treatment

  • conservative surgery group

    Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.

    Other: different surgical treatment

Interventions

  • Otherdifferent surgical treatment

    The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach. Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.

06

What researchers measure

Primary outcomes

  1. successful surgical treatment

    successful treatment rate after surgery

    Time frame: One day after surgery

Secondary outcomes

  1. complication

    severe complication rate after surgery

    Time frame: One day after surgery

Other outcomes

  1. subsequent pregnancy rate

    subsequent pregnancy rate after surgery

    Time frame: Up to 24 months after surgery without contraception and the time since the last menstrual period is 4 weeks or more.

  2. CSP recurrence rate

    CSP recurrence rate after surgery

    Time frame: Up to 24 months after surgery without contraception

  3. pregnancy interval

    pregnancy interval after surgery

    Time frame: Up to 24 months (the time interval between the cessation of contraception after surgery and the time of last menstrual period of the subsequent pregnancy)

07

Study locations

1 of 1 sites recruiting
  • Women's Hospital School Of Medicine Zhejiang University
    Hangzhou, Zhejiang 310006, China
    Recruiting
    • Xiuxiu Jiang, Ph.D · Contactjiangxiuxiu0418@zju.edu.cn · +8613588709941
    • Wanren Zheng, MD · Sub investigator
    • Juan Yu, MD · Sub investigator
    • Meijun Guo, MD · Sub investigator
    • Ning Wang, MD · Sub investigator
    • Shanshan Ni, MD · Sub investigator
    • Xingmiao Li, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Dec 2026, 16 months after the start.

Of 23 observational studies under Cicatrix, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 7. This study's planned 16 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 12, 2025
First posted
May 27, 2026
StartActual
Aug 13, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07608094
Lead sponsor
Women's Hospital School Of Medicine Zhejiang University
Responsible party
Sponsor
First posted
May 27, 2026
Start date
Aug 13, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 12, 2026

Study contacts

xiuxiu jiang, ph.D
Contact
jaingxiuxiu0418@zju.edu.cn
0086-571-87061501
xiuxiu jiang
principal investigator · women's hospital school of medicine Zhejiang uni

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion